Journal article

Role of (Chemo)-Radiotherapy in Resectable Gastric Cancer

M Foo, T Crosby, T Rackley, T Leong

Clinical Oncology | ELSEVIER SCIENCE LONDON | Published : 2014


The prognosis of patients with locally advanced gastric cancer remains poor, despite radical surgical resection. Adjuvant therapy has been shown to improve survival and, in Western countries, is delivered either postoperatively (chemoradiotherapy) or perioperatively (chemotherapy). Debate continues as to which of these represents the optimal strategy. High-dose gastric irradiation comes at the expense of significant toxicity, and increasing efforts have focused on attempts to reduce toxicity and normal tissue doses. The development of advancing radiotherapy technologies now allows improved target delineation and coverage. However, gastric irradiation remains technically challenging and requi..

View full abstract

University of Melbourne Researchers